Objective:
The purpose of this study was to describe the epidemiological, clinical and therapeutic aspects as well as outcome of cutaneous sarcoidosis in Lomé (Togo).
Methods:
The study is a retrospective data analysis of cutaneous sarcoidosis cases seen during a 17- year period (2000-2016) at the dermatology departments in Lomé, Togo.
Results:
In total, 18 cases of cutaneous sarcoidosis were diagnosed; of them, 14 were females and 4 were males. The mean age of the patients was 50.9 years. Cutaneous manifestations were dominated by papules (16 cases) and scars sarcoidosis (12 cases). Locations of lesions were mainly the face (13 cases) and neck (7 cases). Extra cutaneous lesions were essentially lymph nodes (5 cases) and respiratory symptoms (4 cases). Chest X-rays was abnormal in 9 of the 14 patients in whom it had been performed. The pulmonary functional test performed in 3 patients with respiratory involvement showed a restrictive lung syndrome. A tuberculin anergy was found in 2 of the 6 patients in whom tuberculin intradermal test was performed. Patients with isolated cutaneous sarcoidosis were treated with topical corticosteroid (8 cases) or hydroxychloroquine (one case). The nine other patients were treated with oral corticosteroids, which were replaced by methotrexate after a corticodependence in 2 cases. We recorded 4 cases of clinical remission (2 cases of isolated cutaneous sarcoidosis and 2 cases of skin disease with systemic sarcoidosis). The 2 cases of skin disease with systemic sarcoidosis had recurrence 8 months and 12 months later. The remaining 14 patients were lost to follow-up after an average follow-up period of 4 months.
Conclusion:
Our survey shows that the patterns of cutaneous sarcoidosis are similar to that reported from other sub-Saharan African countries with a few distinguishing particularities.